Alessandro WEISZ Curriculum

Personal information

Born: June 24, 1955


1980: M.D. University of Naples

1980: Certification by the Educational Commission for Foreign Medical Graduates (USA)

1980-83: Post-doctoral Fellow, University of Southern California Los Angeles, ‘K. Norris' Cancer Center (USA) and University of California S. Francisco, Dept. of Biochemistry and Biophysics

1986: Oncology Board, University of Naples


1984-88: Staff Researcher, University of Naples, First Faculty of Medicine and Surgery, Napoli, Italy

1988-90: Associate Professor of Molecular Pathology, ibid.

1989-91: Professor of Genetics in charge (affidamento), University of Naples “Federico II” , First Faculty of Medicine and Surgery, Napoli, Italy

1990-2000: Associate Professor of Genetic Pathology, Second University of Naples, Faculty of Medicine and Surgery, Napoli, Italy

2000-2011: Professor of General Pathology, ibid.

2011 to present: Professor of General Pathology, University of Salerno, Faculty of Medicine and Surgery, Baronissi, Italy

Academic (int.l)

1987-89: Fellow of the European Molecular Biology Organization, Univ. ‘L. Pasteur’, Laboratoire de Génetique Moléculaire des Eucaryotes, Strasbourg, France

1992-93, 1996, 1997: Fellow of the Foundation for the Promotion of Cancer Research, National Cancer Center Research Institute, Tokyo and Kashiwa, Japan

1997: Visiting Professor of Biochemistry and Molecular Biology, Inst. d’Etudes et Transfer des Gènes, Universitè de Franche-Comte, Besançon, France

For more information see:

Participation to international research projects

1993-96: Partner in the EU BIOTECH2 project “Control of gene expression by nuclear receptors: Interaction with ligands, DNA and other factors” (Contract BIO2-CT93-0473);

1995, 1996 and 1997: Scientific cooperative projects sponsored by the Conferenza dei Rettori delle Università Italiane, involving Italian and German (Vigoni Program) or French (Galileo Program) Universities;

1998-2001: Partner in the EU BIOMED2 project “Safety of progestins in hormone replacement therapy: Molecular mechanisms and clinical application” (Contract BMH4-CT98-3433);

2005-2011: Partner of the IP “CRESCENDO: Consortium for research into nuclear receptors in development and aging” (Contract LSHM-CT-2005-018652).

2010-2016: Partner of the European Cooperation in Science and Technology (COST) Action "SEQAHEAD: Next Generation Sequencing Data Analysys Network" (Action BM1600)